Proprotein convertase subtilisin/kexin type 6 promotes in vitro proliferation, migration and inflammatory cytokine secretion of synovial fibroblast‑like cells from rheumatoid arthritis via nuclear‑κB, signal transducer and activator of transcription 3 and extracellular signal regulated 1/2 pathways

Jiang,Huiyu; Wang,Lin; Wang,Feifei; Pan,Jihong

doi:10.3892/mmr.2017.7595

Proprotein convertase subtilisin/kexin type 6 promotes in vitro proliferation, migration and inflammatory cytokine secretion of synovial fibroblast‑like cells from rheumatoid arthritis via nuclear‑κB, signal transducer and activator of transcription 3 and extracellular signal regulated 1/2 pathways

Authors:
- Huiyu Jiang
- Lin Wang
- Feifei Wang
- Jihong Pan
View Affiliations

Affiliations: SNP Research Group, Shandong Medicinal Biotechnology Centre, Jinan, Shandong 250062, P.R. China
Published online on: September 25, 2017 https://doi.org/10.3892/mmr.2017.7595
Pages: 8477-8484

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Our previous studies demonstrated that expression of proprotein convertase subtilisin/kexin type 6 (PCSK6) is greatly enhanced in rheumatoid arthritis fibroblast‑like synoviocytes (RASFs), and that PCSK6 inhibition decreases cell proliferation, migration and invasion. The present study aimed to investigate the functional role of PCSK6 in the hyperplasia of RASFs. Cultured RASFs from RA patients were stimulated with recombinant human (rh)PCSK6. Subsequent changes in proliferation, invasion, migration and the secretion of inflammatory cytokines were measured in vitro using MTT, wound healing and Transwell assays, and ELISA. Cell cycle and apoptosis were analyzed by flow cytometry. Influence on downstream gene expression levels were analyzed using reverse transcription‑quantitative polymerase chain reaction. Specific signaling pathways responsible for these effects were analyzed using western blotting and confirmed with pathway‑specific inhibitors. It was demonstrated that rhPCSK6 significantly increased RASF cell invasion, migration and proliferation, which was influenced through both reduced cell cycle arrest and reduced apoptosis. Furthermore, rhPCSK6 stimulated RASFs to secrete the inflammatory cytokines interleukin (IL)‑1α, IL‑1β and IL‑6, and exhibit altered expression of genes involved in angiogenesis, hypoxia, proliferation and inflammation. These cellular effects were mediated via the nuclear factor (NF)‑κB, signal transducer and activator of transcription 3 (STAT3) and extracellular signal regulated (ERK)1/2 signaling pathways. The results demonstrated that signaling via NF‑κB and STAT3 mediated cell cycle arrest, and signaling through NF‑κB mediated apoptosis in RASF cells stimulated with PCSK6. PCSK6 can activate NF‑κB, STAT3 and ERK1/2 signaling pathways in vitro to enhance cell proliferation, migration, invasion and inflammation in RASF cells. These findings suggest that PCSK6 may be an important therapeutic target in RA.

View Figures

View References

1	Sokka T: Work disability in early rheumatoid arthritis. Clin Exp Rheumatol. 21(5 Suppl 31): S71–S74. 2003.PubMed/NCBI
2	Noss EH and Brenner MB: The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev. 223:252–270. 2008. View Article : Google Scholar : PubMed/NCBI
3	Tchetverikov I, Lard LR, De Groot J, Verzijl N, TeKoppele JM, Breedveld FC, Huizinga TW and Hanemaaijer R: Matrix metalloproteinases-3, −8, −9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis. 62:1094–1099. 2003. View Article : Google Scholar : PubMed/NCBI
4	Tolboom TC, Van der Helm-van Mil AH, Nelissen RG, Breedveld FC, Toes RE and Huizinga TW: Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 52:1999–2002. 2005. View Article : Google Scholar : PubMed/NCBI
5	Cunnane G, Fitzgerald O, Hummel KM, Youssef PP, Gay RE, Gay S and Bresnihan B: Synovialtissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum. 44:1744–1753. 2001. View Article : Google Scholar : PubMed/NCBI
6	Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, López-Otín C and Takagi M: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 58:691–697. 1999. View Article : Google Scholar : PubMed/NCBI
7	Xue M, March L, Sambrook PN and Jackson CJ: Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: Relevance to inflammation in rheumatoid arthritis. Arthritis Rheum. 56:2864–2874. 2007. View Article : Google Scholar : PubMed/NCBI
8	Nagase H, Visse R and Murphy G: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 69:562–573. 2006. View Article : Google Scholar : PubMed/NCBI
9	van den Steen PE, Grillet B and Opdenakker G: Gelatinase B participates in collagen II degradation and releases glycosylated remnant epitopes in rheumatoid arthritis. Adv Exp Med Biol. 564:45–55. 2005. View Article : Google Scholar : PubMed/NCBI
10	Charni-Ben Tabassi N, Desmarais S, Bay-Jensen AC, Delaissé JM, Percival MD and Garnero P: The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. Osteoarthritis Cartilage. 16:1183–1191. 2008. View Article : Google Scholar : PubMed/NCBI
11	Mahloogi H, Bassi DE and Klein-Szanto AJ: Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4. Carcinogenesis. 23:565–572. 2002. View Article : Google Scholar : PubMed/NCBI
12	Wang F, Wang L, Jiang H, Chang X and Pan J: Inhibition of PCSK6 may play a protective role in the development of rheumatoid arthritis. J Rheumatol. 42:161–169. 2015. View Article : Google Scholar : PubMed/NCBI
13	Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T and Wolfe F: The American college of rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 35:498–502. 1992. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Bartok B and Firestein GS: Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
16	Posada J and Cooper JA: Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes. Science. 255:212–215. 1992. View Article : Google Scholar : PubMed/NCBI
17	Walker JG and Smith MD: The Jak-STAT pathway in rheumatoid arthritis. J Rheumatol. 32:1650–1653. 2005.PubMed/NCBI
18	Roman-Blas JA and Jimenez SA: NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 14:839–848. 2006. View Article : Google Scholar : PubMed/NCBI
19	Zhang Q, Wu J, Cao Q, Xiao L, Wang L, He D, Ouyang G, Lin J, Shen B, Shi Y, et al: A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 60:3602–3612. 2009. View Article : Google Scholar : PubMed/NCBI
20	Mains RE, Berard CA, Denault JB, Zhou A, Johnson RC and Leduc R: PACE4: A subtilisin-like endoprotease with unique properties. Biochem J. 321:587–593. 1997. View Article : Google Scholar : PubMed/NCBI
21	Seidah NG, Chrétien M and Day R: The family of subtilisin/kexin like pro-protein and pro-hormone convertases: Divergent or shared functions. Biochimie. 76:197–209. 1994. View Article : Google Scholar : PubMed/NCBI
22	Tsuji A, Hashimoto E, Ikoma T, Taniguchi T, Mori K, Nagahama M and Matsuda Y: Inactivation of proprotein convertase, PACE4, by alpha1-antitrypsin Portland (alpha1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: Evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha1-PDX. J Biochem. 126:591–603. 1999. View Article : Google Scholar : PubMed/NCBI
23	Huber LC, Distler O, Tarner I, Gay RE, Gay S and Pap T: Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford). 45:669–675. 2006. View Article : Google Scholar : PubMed/NCBI
24	Xue M, McKelvey K, Shen K, Minhas N, March L, Park SY and Jackson CJ: Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation. Rheumatology (Oxford). 53:2270–2279. 2014. View Article : Google Scholar : PubMed/NCBI
25	Brenner M and Gulko PS: The arthritis severity locus Cia5a regulates the expression of inflammatory mediators including Syk pathway genes and proteases in pristane-induced arthritis. BMC Genomics. 13:7102012. View Article : Google Scholar : PubMed/NCBI
26	Perisic L, Hedin E, Razuvaev A, Lengquist M, Osterholm C, Folkersen L, Gillgren P, Paulsson-Berne G, Ponten F, Odeberg J and Hedin U: Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 33:2432–2443. 2013. View Article : Google Scholar : PubMed/NCBI
27	D'Anjou F, Routhier S, Perreault JP, Latil A, Bonnel D, Fournier I, Salzet M and Day R: Molecular validation of PACE4 as a target in prostate cancer. Transl Oncol. 4:157–172. 2011. View Article : Google Scholar : PubMed/NCBI
28	Chu IM, Hengst L and Slingerland JM: The Cdk inhibitor p27 in human cancer: Prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008. View Article : Google Scholar : PubMed/NCBI
29	Pagès G, Lenormand P, L'Allemain G, Chambard JC, Meloche S and Pouysségur J: Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA. 90:pp. 8319–8323. 1993; View Article : Google Scholar : PubMed/NCBI